HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Amantadine

HCID 2130
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
768-94-5
Standard SMILES
NC12CC3CC(CC(C3)C1)C2
InChIKey
DKNWSYNQZKUICI-UHFFFAOYSA-N
Molecular formula
C10H17N
Average molar mass
151.25 g/mol
Monoisotopic mass
151.13609955

Overview

Amantadine is a member of the class of adamantanes that is used as an antiviral and antiparkinson drug. It has a role as an analgesic, a non-narcotic analgesic, an antiviral drug, an antiparkinson drug, a dopaminergic agent and a NMDA receptor antagonist. It is a primary aliphatic amine and a member of adamantanes. It is a conjugate base of an adamantan-1-aminium. It derives from a hydride of an adamantane.

Names & identifiers

Preferred name
Amantadine
IUPAC
adamantan-1-amine
English name
Amantadine
Molecular formula
C10H17N
Molecular weight
151.25

Names & synonyms

amantadine1-Adamantanamine768-94-5adamantan-1-amine1-Adamantylamine1-AminoadamantaneAdamantanamineAdamantylamineAmantidineAminoadamantaneAdamantaminePk-merz
Show more names
(3s,5s,7s)-adaMantan-1-aMine
AmantadinaAmantadinumGocovriEndantadineViregytNSC-341865DTXSID8022117Tricyclo[3.3.1.13,7]decan-1-amine

Database identifiers

CAS
768-94-5
PubChem CID
2130
DTXSID
DTXSID8022117
ChEMBL
CHEMBL660
ChEBI
CHEBI:2618
UNII
BF4C9Z1J53
EC Number
212-201-2
Nikkaji
J6.971J

Properties

Computed structural properties

XLogP
2.4
Topological polar surface area
26 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
1
Rotatable bonds
0
Heavy atoms
11
Formal charge
0
Complexity
144

Experimental & physicochemical properties

Drugs · 2 items

Pharmaceuticals

Pharmaceuticals -> Listed in ZINC15

SpringerMaterials Properties15N nuclear magnetic resonance spectrum
LogP · 3 items

log Kow = 2.44

2.3

2.54

Color/FormHEXAKISTETRAHEDRAL CRYSTALS BY SUBLIMATION
Solubility · 3 items

Stable, white or nearly white crystalline powder. Crystals from abs ethanol+ anhydr ether. Decomp at 360 °C. Practically insol in ether; sol in water (at least 1:20). /Hydrochloride/

Sparingly sol in water

8.46e-02 g/L

Human Drugs · 3 items

Breast Feeding; Lactation; Milk, Human; Anti-Infective Agents; Antiparkinson Agents; Antiviral Agents; Dopamine Agents

FDA approved drugs -> Active ingredient

Pharmaceuticals

Melting Point · 3 items

180-192

160-190 °C (closed tube); Also reported as 180-192 °C

180 °C

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P260, P261, P264, P264+P265, P270, P271, P273, P280, P301+P317, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P351+P338, P305+P354+P338, P316, P317, P318, P319, P321, P330, P332+P317, P337+P317, P362+P364, P363, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 156 reports by companies from 10 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Regulatory Information · 2 items

Chemical: Tricyclo[3.3.1.13,7]decan-1-amine

REACH registered substance: Amantadine (EC: 212-201-2)

FDA Requirements · 1 item

The Approved Drug Products with Therapeutic Equivalence Evaluations List identifies currently marketed prescription drug products, incl amantadine hydrochloride, approved on the basis of safety and effectiveness by FDA under sections 505 of the Federal Food, Drug, and Cosmetic Act. /Amantadine hydrochloride/

Hazard Classes and CategoriesAcute Tox. 4 (100%)

Safety & protection

Disposal Methods · 1 item

SRP: The most favorable course of action is to use an alternative chemical product with less inherent propensity for occupational exposure or environmental contamination. Recycle any unused portion of the material for its approved use or return it to the manufacturer or supplier. Ultimate disposal of the chemical must consider: the material's impact on air quality; potential migration in soil or water; effects on animal, aquatic, and plant life; and conformance with environmental and public health regulations.

Chemistry & industry

Pharmacology

ATC Code · 3 items

N04BB01

N - Nervous system

QN - Nervous system

Protein BindingApproximately 67% bound to plasma proteins over a concentration range of 0.1 to 2.0 µg/mL.
Pharmacodynamics · 1 item

Amantadine is an antiviral drug which also acts as an antiparkinson agent, for which it is usually combined with L-DOPA when L-DOPA responses decline (probably due to tolerance). It is a derivate of adamantane, like a similar drug rimantadine. The mechanism of action of amantadine in the treatment of Parkinson's disease and drug-induced extrapyramidal reactions is not known. It has been shown to cause an increase in dopamine release in the animal brain, and does not possess anticholinergic activity.

Mechanism of Action · 5 items

The mechanism of its antiparkinsonic effect is not fully understood, but it appears to be releasing dopamine from the nerve endings of the brain cells, together with stimulation of norepinephrine response. It also has NMDA receptor antagonistic effects. The antiviral mechanism seems to be unrelated. The drug interferes with a viral protein, M2 (an ion channel), which is needed for the viral particle to become "uncoated" once it is taken inside the cell by endocytosis.

Amantadine, like rimantadine, inhibits viral replication by interfering with the influenza A virus M2 protein, an integral membrane protein. The M2 protein of influenza A functions as a ion channel and is important in at least 2 aspects of virus replication, disassembly of the infecting virus particle and regulation of the ionic environment of the transport pathway. By interfering with the ion channel function of the M2 protein, amantadine inhibits 2 stages in the replicative cycle of influenza A. Early in the virus replicative cycle, amantadine inhibits uncoating of the virus particle, presumably by inhibiting the acid-mediated dissociation of the virion nucleic acid and proteins, which prevents nuclear transport of viral genome material. Amantadine also prevents viral maturation in some strains of influenza A (e.g., H7 strains) by promoting pH-induced conformational changes in influenza A hemagglutinin during its intracellular transport late in the replicative cycle. Adsorption of the virus to and penetration into cells do not appear to be affected by amantadine. In addition, amantadine does not interfere with the synthesis of viral components (e.g., RNA-directed RNA polymerase activity).

Related reactions

161 records
New reaction record
HRID 5494 reaction equation
HRID 5494As reactant
HRID 8671 reaction equation
HRID 8671As reactant
HRID 8692 reaction equation
HRID 8692As reactant
HRID 11442 reaction equation
HRID 11442As reactant
HRID 18385 reaction equation
HRID 18385As reactant
HRID 41655 reaction equation
HRID 41655As reactant
HRID 66089 reaction equation
HRID 66089As reactant
HRID 74205 reaction equation
HRID 74205As reactant
PreviousPage 1 of 21

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Physical DescriptionSolid
Stability/Shelf LifeStable in light, heat & air /Amantadine hydrochloride/
Dissociation Constants · 2 items

10.58

10.68

Other Experimental Properties · 1 item

ODORLESS; BITTER TASTE; DOES NOT MELT UP TO 300 °C, BUT SUBLIMES SLOWLY; PKA: 10.36 AT 30 °C; PH (1 IN 5 SOLN) BETWEEN 3.0 & 5.5. WHITE OR NEARLY WHITE CRYSTALLINE POWDER; 1 G IN 2.5 ML WATER, 5.1 ML ALCOHOL, 18 ML CHLOROFORM, 70 ML POLYETHYLENE GLYCOL 400 /AMANTADINE HYDROCHLORDIE/

Physicochemical properties

Melting point
206 · 206-208 °C(lit.)
Boiling point
263.29 °C · 263.29°C (rough estimate)
Density
0.951 · 0.9510 (rough estimate)
refractive index
1.522 · 1.5220 (estimate)
storage temp.
Keep in dark place,Inert atmosphere,Room temperature
solubility
1 M · 1 M HCl: soluble5%, clear to hazy, colorless to faint yellow or tan
form
Powder
pka
10.1 · 10.1(at 25℃)
color
White to cream
Water Solubility
Soluble in organic solvents. Insoluble in water.
Merck
14 · 14,374
BRN
2204333 · 2204333
Major Application
food and beveragespersonal carepharmaceutical
InChI
1S/C10H17N/c11-10-4-7-1-8(5-10)3-9(2-7)6-10/h7-9H,1-6,11H2/t7-,8+,9-,10-
InChIKey
DKNWSYNQZKUICI-UHFFFAOYSA-N
SMILES
NC12C[C@H]3C[C@H](C[C@H](C3)C1)C2
CAS DataBase Reference
768 · 768-94-5(CAS DataBase Reference)
FDA UNII
4 C9Z1J53 · BF4C9Z1J53
NCI Drug Dictionary
Symadine
ATC code
4 BB01 · N04BB01
NIST Chemistry Reference
3.3 · Tricyclo[3.3.1.13,7]decane-1-amine(768-94-5)
EPA Substance Registry System
3.3 · Tricyclo[3.3.1.13,7]decan-1-amine (768-94-5)
UNSPSC Code
12352100 · 12352100
NACRES
22 · NA.22
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302-H315-H319-H335
Precautionary statements
301 · P301+P312+P330-P302+P352-P305+P351+P338
target organs
Respiratory system
Hazard Codes
Xn,Xi
Risk Statements
22 · 22-36/37/38
Safety Statements
26 · 26-36
WGK Germany
3 · 3
RTECS
1925000 · YD1925000
F
10 · 10-34
TSCA
TSCA listed
HS Code
2921300090 · 2921300090
Storage Class
11 · 11 - Combustible Solids
Hazard Classifications
4 OralEye · Acute Tox. 4 OralEye Irrit. 2Skin Irrit. 2STOT SE 3
Hazardous Substances Data
768 · 768-94-5(Hazardous Substances Data)
Toxicity
50 oral · LD50 oral in rat: 900mg/kg
REACH Registrations
Active

Toxicology

Treatment · 1 item

There is no specific antidote for an overdose of Amantadine. However, slowly administered intravenous physostigmine in 1 and 2 mg doses in an adult2 at 1- to 2-hour intervals and 0.5 mg doses in a child3 at 5- to 10-minute intervals up to a maximum of 2 mg/hour have been reported to be effective in the control of central nervous system toxicity caused by amantadine hydrochloride. For acute overdosing, general supportive measures should be employed along with immediate gastric lavage or induction of emesis. Fluids should be forced, and if necessary, given intravenously. The pH of the urine has been reported to influence the excretion rate of Amantadine. (L1744)

Interactions · 5 items

The anti-influenza A activities of amantadine and ribavirin were investigated seperately and in combination. In ferret tracheal ciliated epithelium, the combination of drugs synergistically delayed the virus-induced cytopathic effect.

Concurrent use /of alcohol/ with amantadine is not recommended since this may increase the potential for CNS effects such as dizziness, lightheadedness, orthostatic hypotension, or confusion.

Concurrent use /of anticholinergics, or other medications with anticholinergic activity; tricyclic antidepressants; other antidyskinetics; antihistamines; or phenothiazines/ with amantadine may potentiate the anticholinergic-like side effects, especially those of confusion, hallucinations, and nightmares; dosage adjustments of these medications or of amantadine may be necessary; also, patients should be advised to report occurrences of gastrointestinal problems promptly since paralytic ileus may occur with concurrent therapy.

Concurrent use /of opioid- and anticholinergic-containing antidiarrheals/ with amantadine may potentiate the anticholinergic-like side effects; although significant interaction is unlikely with usual doses of opioid- and anticholinergic-containing antidiarrheals, significant interaction may occur if these medications are abused.

For more Interactions (Complete) data for AMANTADINE (10 total), please visit the HSDB record page.

Health Effects · 1 item

Acute overdosage of amantadine has resulted in cardiac dysfunction (e.g., arrhythmia, tachycardia, hypertension); pulmonary edema and respiratory distress (including adult respiratory distress syndrome); renal dysfunction (e.g., increased BUN, decreased creatinine clearance, renal insufficiency); or CNS toxicity (e.g., insomnia, anxiety, psychotic reactions, lethargy, somnolence, coma). Hyperthermia also has occurred with amantadine overdosage. In addition, seizures may be exacerbated in patients with a history of a seizure disorder (A620).

HepatotoxicityDespite widespread use, there is little evidence that amantadine when given orally causes liver injury, either in the form of serum enzyme elevations or clinically apparent liver disease.
Environmental Fate · 3 items

TERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 385(SRC), determined from a structure estimation method(2), indicates that amantadine is expected to have moderate mobility in soil(SRC). The pKa of amantadine is estimated as 10.45(SRC), using a method based on perturbed molecular orbital theory and linear free energy (LFER) methods(3). This pKa value indicates that amantadine will exist primarily in its protonated form in the environment and cations tend to adsorb to soils stronger than neutral molecules(4). Amantadine will not volatilize from moist soil surfaces since cations do not volatilize. Amantadine is not expected to volatilize from dry soil surfaces(SRC) based upon an estimated vapor pressure of 0.13 mm Hg(SRC), determined from a fragment constant method(5). Biodegradation data were not available(SRC, 2006).

AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 385(SRC), determined from a structure estimation method(2), indicates that amantadine is expected to adsorb to suspended solids and sediment(SRC). The pKa of amantadine is estimated as 10.45(SRC), using a method based on perturbed molecular orbital theory and linear free energy (LFER) methods(3). This pKa value indicates that amantadine will exist primarily in its protonated form in the environment and cations do not volatilize from water(4). According to a classification scheme(5), an estimated BCF of 15(SRC), from a log Kow of 2.44(6) and a regression-derived equation(7), suggests the potential for bioconcentration in aquatic organisms is low (SRC). Biodegradation data were not available(SRC, 2006).

ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), amantadine, which has an estimated vapor pressure of 0.13 mm Hg at 25 °C(SRC), determined from a fragment constant method(2), is expected to exist solely as a vapor in the ambient atmosphere. Vapor-phase amantadine is degraded in the atmosphere by reaction with photochemically-produced hydroxyl radicals(SRC); the half-life for this reaction in air is estimated to be 10 hours(SRC), calculated from its rate constant of 4.0X10-11 cu cm/molecule-sec at 25 °C(SRC) that was derived using a structure estimation method(3).

Adverse Effects · 1 item

The main advantage of amantadine is that it has a low side effect profile. The primary adverse effects of amantadine may include orthostatic hypotension, syncope, peripheral edema, dizziness, delusions, hallucinations, falls, xerostomia, and constipation. Although livedo reticularis is a less common side effect, amantadine is one of the best-known drugs to cause it. This side effect is reversible with the withdrawal of medication. Serious adverse effects include neuroleptic malignant syndrome, psychosis, suicidal ideation, and CNS depression. Central nervous system (CNS) depression requires monitoring, especially in the elderly. Providers should caution patients against activities that require physical and mental alertness, such as driving and avoid combination with other CNS depressing agents, such as alcohol. Caution with usage and dosage adjustments may be necessary for those with heart disease, seizure disorder, hepatic impairment, and renal impairment.

Exposure RoutesInhalation. Amantadine is well absorbed orally from the gastrointestinal tract.
Milk ConcentrationsAmantadine is distributed into breast milk.
Toxicity Summary · 2 items

There currently is no minimum toxicity dose listed. The limitation for increased doses beyond 400 mg per day is due to CNS effects. It is essential to know the patient's history of mental illness and seizures before proceeding with therapy. Toxicity may manifest as acute psychosis, cardiovascular toxicity, coma, and/or death. Although there is no antidote for amantadine, side effects resolve with discontinuation of usage. Some preparations of the drug may contain propylene glycol. Large amounts of propylene glycol can potentially be toxic and cause hyperosmolality, lactic acidosis, respiratory depression, and seizures. In addition, Amantadine toxicity is a concern in patients with severe renal impairment, as 90% of the dose administered orally is excreted unchanged in the urine.

The mechanism of its antiparkinsonic effect is not fully understood, but it appears to be releasing dopamine from the nerve endings of the brain cells, together with stimulation of norepinephrine response. It also has NMDA receptor antagonistic effects. The antiviral mechanism seems to be unrelated. The drug interferes with a viral protein, M2 (an ion channel), which is needed for the viral particle to become "uncoated" once it is taken inside the cell by endocytosis.

Signs and Symptoms · 1 item

Deaths have been reported from overdose with amantadine. The lowest reported acute lethal dose was 2 grams. Drug overdose has resulted in cardiac, respiratory, renal or central nervous system toxicity. Cardiac dysfunction includes arrhythmia, tachycardia and hypertension. Pulmonary edema and respiratory distress (including ARDS) have been reported. Renal dysfunction including increased BUN, decreased creatinine clearance and renal insufficiency can occur. Central nervous system effects that have been reported include insomnia, anxiety, aggressive behavior, hypertonia, hyperkinesia, tremor, confusion, disorientation, depersonalization, fear, delirium, hallucination, psychotic reactions, lethargy, somnolence and coma. Seizures may be exacerbated in patients with prior history of seizure disorders. Hyperthermia has also been observed in cases where a drug overdose has occurred.

Effluent ConcentrationsAmantadine was identified, not quantified, in the effluent of municipal sewage treatment plants in Stuttgart, Germany in 1999(1).
Soil Adsorption/Mobility · 1 item

Using a structure estimation method based on molecular connectivity indices(1), the Koc for amantadine can be estimated to be 385(SRC). According to a classification scheme(2), this estimated Koc value suggests that amantadine is expected to have moderate mobility in soil(SRC). The pKa of amantadine is estimated as 10.45(SRC), using an estimation method based on perturbed molecular orbital theory and linear free energy (LFER) methods(3). This estimated pKa indicates that amantadine will exist primarily in the protonated form in the environment and cations generally adsorb more strongly to organic carbon and clay than their neutral counterparts(4).

Regulatory information

FDA Requirements · 1 item

The Approved Drug Products with Therapeutic Equivalence Evaluations List identifies currently marketed prescription drug products, incl amantadine hydrochloride, approved on the basis of safety and effectiveness by FDA under sections 505 of the Federal Food, Drug, and Cosmetic Act. /Amantadine hydrochloride/

Safety data

F
10-34
wgk
3
tsca
TSCA listed
rtecs
YD1925000
hs_code
2921300090
Toxicity
LD50 oral in rat: 900mg/kg
risk_code
22-36/37/38
Signal word
Warning
Symbol(GHS)
GHS07
hazard_code
Xn,Xi
safety_code
26-36
Storage Class
11 - Combustible Solids
target organs
Respiratory system
Hazard statements
H302-H315-H319-H335
REACH Registrations
Active
Hazard Classifications
Acute Tox. 4 OralEye Irrit. 2Skin Irrit. 2STOT SE 3
Precautionary statements
P301+P312+P330-P302+P352-P305+P351+P338
Hazardous Substances Data
768-94-5(Hazardous Substances Data)

The mechanism of action of amantadine in the treatment of Parkinson's disease and drug-induced extrapyramidal reactions is not known. Data from earlier animal studies suggest that symmetrel may have direct and indirect effects on dopamine neurons. More recent studies have demonstrated that amantadine is a weak, non-competitive NMDA receptor antagonist (Ki = 10 uM). Although amantadine has not been shown to possess direct anticholinergic activity in animal studies, clinically, it exhibits anticholinergic-like side effects such as dry mouth, urinary retention, and constipation.

The mechanism by which amantadine exerts its antiviral activity is not clearly understood. It appears to mainly prevent the release of infectious viral nucleic acid into the host cell by interfering with the function of the transmembrane domain of the viral M2 protein. In certain cases, amantadine is also known to prevent virus assembly during virus replication. It does not appear to interfere with the immunogenicity of inactivated influenza A virus vaccine.

In isolated ventricular muscle preparations (frog, rabbit, cat, dog, and calf) amantadine increased the action potential duration, decreased the amplitude and max diastolic potential, and induced phase 4 depolarization. These changes may be due to the effect of amantadine on potassium ion conductance.

Biological Half-Life · 4 items

Mean half-lives ranged from 10 to 14 hours, however renal function impairment causes a severe increase in half life to 7 to 10 days.

Amantadine pharmacokinetics were determined in 24 normal adult male volunteers after the oral administration of a single amantadine hydrochloride 100 mg soft gel capsule. ... The half-life was 17 + or - 4 hours (range: 10 to 25 hours). Across other studies, amantadine plasma half-life has averaged 16 + or - 6 hours (range: 9 to 31 hours) in 19 healthy volunteers.

Normal renal function: 11 to 15 hours. Elderly patients: 24 to 29 hours. Renal function impairment, severe: 7 to 10 days. Hemodialysis: 24 hours.

The elimination half-life increases two to three fold or greater when creatinine clearance is less than 40 mL/min/1.73 sqm and averages eight days in patients on chronic maintenance hemodialysis.

Metabolism/Metabolites · 3 items

No appreciable metabolism, although negligible amounts of an acetyl metabolite have been identified.

Eight metabolites of amantadine have been identified in human urine. One metabolite, an N-acetylated compound, was quantified in human urine and accounted for 5-15% of the administered dose. Plasma acetylamantadine accounted for up to 80% of the concurrent amantadine plasma concentration in 5 of 12 healthy volunteers following the ingestion of a 200 mg dose of amantadine. Acetylamantadine was not detected in the plasma of the remaining seven volunteers..

No appreciable metabolism, although negligible amounts of an acetyl metabolite have been identified. Amantadine is well absorbed orally from the gastrointestinal tract. The mechanism of its antiparkinsonic effect is not fully understood, but it appears to be releasing dopamine from the nerve endings of the brain cells, together with stimulation of norepinephrine response. The antiviral mechanism seems to be unrelated. The drug interferes with a viral protein, M2 (an ion channel), which is needed for the viral particle to become "uncoated" once it is taken inside the cell by endocytosis. Metabolites are excreted in the urine (A308). Route of Elimination: It is primarily excreted unchanged in the urine by glomerular filtration and tubular secretion. Half Life: Mean half-lives ranged from 10 to 14 hours, however renal function impairment causes a severe increase in half life to 7 to 10 days.

FDA Pharmacological Classification · 6 items

BF4C9Z1J53

AMANTADINE

Established Pharmacologic Class [EPC] - Influenza A M2 Protein Inhibitor

Mechanisms of Action [MoA] - M2 Protein Inhibitors

Amantadine is an Influenza A M2 Protein Inhibitor. The mechanism of action of amantadine is as a M2 Protein Inhibitor.

AMANTADINE

MeSH Pharmacological Classification · 4 items

Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists.

Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.

Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons.

A subclass of analgesic agents that typically do not bind to OPIOID RECEPTORS and are not addictive. Many non-narcotic analgesics are offered as NONPRESCRIPTION DRUGS.

Absorption, Distribution and Excretion · 6 items

Amantadine is well absorbed orally from the gastrointestinal tract.

It is primarily excreted unchanged in the urine by glomerular filtration and tubular secretion.

3 to 8 L/kg [healthy subjects]

0.2 - 0.3 L/hr/kg

Rapidly and almost completely absorbed from gastrointestinal tract.

Amantadine is distributed into breast milk.

Cellular LocationsCytoplasm

Uses & manufacturing

Uses · 6 items

MEDICATION (VET)

Used as a chemical intermediate for the synthesis of tromantadine.

Antiviral and treatment for Parkinson's disease

Analgesics, Non-Narcotic; Antiparkinson Agents; Antiviral Agents; Dopamine Agents

Prevent infection with various strains of influenza A virus.

Use (kg; approx.) in Germany (2009): >2500

Methods of Manufacturing · 2 items

Amantadine is brominated to 1-bromo compound, which is then reacted with acetonitrile in presence of sulfuric acid to produce n-(1-adamantanyl)acetamide. Alkaline hydrolysis liberates amantadine, which is reacted with hydrogen chloride in suitable solvent to yield official salt. /amantadine hydrochloride/

1-Bromoadamantane + acetonitrile (Ritter reaction)

Formulations/Preparations · 3 items

Oral: Capsules, liquid-filled Tablets: 100 mg (available by nonpropriety name), 100 mg, Symmetrel, (Endo); Solution: 50 mg/5 mL, Symmetrel Syrup ( with parabens), (Endo).

Trade Names.Hydrochloride: Amazolon (Sawai), Mantadine (Du Pont), Mantadix (Du Pont, Rhône-Poulenc), Symmetrel (Ciba-Geigy), Virofral (Ferrosan). Sulfate: Contenton (SKD), PK-Merz (Merz).

administered PO, intranasal, SC, IP, or aerosol routes.

Use ClassificationPharmaceuticals
General Manufacturing Information · 2 items

Tricyclo[3.3.1.13,7]decan-1-amine: ACTIVE

Available commercially as the free base or the hydrochloride, sulfate, or fumarate salts.

Applications · 5 items

DescriptionAmantadine is an agent that raises the concentration of dopamine in the synaptic cleft by releasing it from neurons and suppressing the process of reuptake.

UsesBuilding block for an L-piperidinamide catalyst used in an enantioselective Strecker reaction of phosphinoyl imines.1

UsesAmantadine is a primary amine derivative of adamantane. It has an effect on mycoviruses, which are RNA-containing viruses. It has a very narrow spectrum of action and is used only for treating and preventing influenza A. It is also used for treating Parkinsonism. The exact mechanism of antiviral action of amantadine is not completely understood. It is believed that it is an ion channel blocker. It has also been suggested that amantadine inhibits absorption of viral particles into the host cell, which is expressed in the breakdown of diffusion of the virus into the cell, or inhibition of the “stripping process” of the virus. The main use is for the prevention of type A2 influenza. Synonyms of this drug are simmetrel, viregit, mantadan, and others.

UsesAmantadine is an antiviral drug. The properties in amantadine, which relieve symptoms of Parkinsonism were discovered by accident. Treatment of Parkinsonism with a combination of levodopa, anticholinergic drugs, and amantadine gives better results than using any of these drugs individually.

General DescriptionAmantadine has been used for years as a treatment for Parkinson disease. The adamantanamines have twomechanisms in common:they inhibit an early step in viralreplication, most likely viral uncoating,and in somestrains, they affect a later step that probably involves viral assembly,possibly by interfering with hemagglutinin processing.The main biochemical locus of action is the influenzatype A virus M2 protein, which is an integral membrane proteinthat functions as an ion channel. The M2 channel is a protontransport system. By interfering with the function of theM2 protein, the adamantanamines inhibit acid-mediated dissociationof the ribonucleoprotein complex early in replication.They also interfere with transmembrane proton pumping,maintaining a high intracellular proton concentrationrelative to the extracellular concentration and enhancingacidic pH-induced conformational changes in the hemagglutininduring its intracellular transport at a later stage. The conformationalchanges in hemagglutinin prevent transfer of thenascent virus particles to the cell membrane for exocytosis.

Upstream & downstream products

Upstream raw materials

AdamantaneDistillatorIndustrial glass lining reaction vesselSodium bisulfite solutionBromine

Downstream products

1-Adamantanamine hydrochloride1-Adamantyl isothiocyanateN-Adamantan-1-yl-phthalamic acidCHEMBRDG-BB 56361131-(1-Adamantyl)pyrrolidin-2-one

Additional notes

DefinitionChEBI: A member of the class of adamantanes that is used as an antiviral and antiparkinson drug.